| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.2 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |